Clinical Role - Payer
Pharmacy Times® is a leader in providing the latest clinical updates, patient counseling tools and innovative solutions to payers, pharmacy benefit managers, formulary chairs and directors, managed care directors, quality assurance directors, and Medicaid/Medicare directors.
Technology can help revolutionize how a pharmacy manages patients, collects payments, communicates, and can improve overall efficiency.
Protections for covered entities under the 340B program will most likely be affected by decisions in the Senate.
Data standardization has been an ongoing problem in the specialty pharmacy field, affecting both patients and providers when approaching treatments.
During the COVID-19 pandemic, many families and individuals have not been able to pay their out-of-pocket costs or do not have enough money saved to pay their deductibles.
Political insiders Donna L. Brazile and Michael Steele spoke to NASP members about which issues may concern them most and getting involved in the political process.
Researchers found that although the number of Medicare beneficiaries increased between 2014 and 2018, total costs decreased.
The terms of participation in the phase 2 round of the Provider Relief Fund created an unintended exclusion for pharmacies that primarily serve Medicaid/Children’s Health Insurance Program patients.
Racial and economic disparities are especially pronounced among patients on Medicare, study shows.
The goals of specialty pharmacy programs are to reduce or delay progression of the disease, improve patient outcomes, enhance patients’ quality of life, keep patients in the workforce longer, and decrease total health care costs.
With election season intensifying, 35% of voters said drug pricing is among the most important issues influencing their vote in November.
Patient assistance programs are often the difference between accessing the drug and increasing abandonment rate.
More than 40 million unemployment claims have been filed over the course of the COVID-19 pandemic.